Drugs / KRN330
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00575562 | Jun 2007 → Jan 2010 | colorectal cancer | Kyowa Kirin, Inc. | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00838578 | Mar 2009 → Jul 2012 | colorectal cancer | Kyowa Kirin, Inc. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KRN330 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00575562 ↗ |
| Modality | Monoclonal antibody | “Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer” NCT00575562 ↗ |
| Target | GPA33 | “Cell surface A33 antigen binding agent” CHEMBL2109293 ↗ |